NICE issues appraisal for TNF alpha inhibitors for RA

The U.K.'s National Institute for Health and Clinical Excellence (NICE) recommended that TNF alpha inhibitors Humira adalimumab and Enbrel etanercept

Read the full 205 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE